Summary
We studied the effect of aminoguanidine, an inhibitor of advanced glycation product formation, on albuminuria in chronically diabetic spontaneously hypertensive rats. At the time of killing, there was no statistically significant difference in blood glucose concentration between the treated and untreated diabetic animals (18.2±0.69 mmol/l), nor was there any difference among the non-diabetic, diabetic untreated, and diabetic treated rats with respect to blood pressure (169±6.9 mm Hg). However, non-diabetic hypertensive animals had a mean quantitative 24-h urinary albumin excretion of 28±2 mg albumin/24-h, while untreated diabetic hypertensive animals averaged nearly four times that amount (106 ±3 mg albumin/24 h). Without affecting blood pressure, aminoguanidine treatment of diabetic hypertensive animals decreased the diabetic-associated elevation in urinary albumin excretion by 75% (48±2 mg/24 h). These data suggest than inhibition of advanced glycation product formation ameliorates the glomerular dysfunction caused by chronic hyperglycaemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Krolewski AS, Warram JH, Christleib AR et al. (1985) The changing natural history of nephropathy in type 1 diabetes. Am J Med 78: 785–794
Brownlee M, Sherwood LM (1990) Diabetes mellitus and its complications: pathogenesis and treatment. Hanley & Belfus, Philadelphia
Berkman J, Rifkin H (1973) Unilateral nodular diabetic glomerulosclerosis. Metabolism 22: 715–722
Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen Paa (1987) Effect of anti-hypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447
Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A (1986) Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232: 1629–1632
Fein FS, Zola BE, Malhotra A, Cho S, Factor SM, Scheuer J (1990) Hypertensive-diabetic cardiomyopathy in rats. Am J Physiol 258: H793–805
Nicholls K, Mandel TE (1989) Advanced glycosylation endproducts in experimental murine diabetic nephropathy. Lab Invest 60: 486–493
Ellis EN, Bowen W (1990) Aminoguanidine ameliorates glomerular basement membrane thickening in experimental diabetes. Diabetes 39 [Suppl 1]: 71A (Abstract)
Kihara M, Schmelzer JD, Poduslo JF, Curran FF, Nickander KK, Low PA (1991) Aminoguanidine effect on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88: 6107–6111
Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315–1321
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edelstein, D., Brownlee, M. Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 35, 96–97 (1992). https://doi.org/10.1007/BF00400859
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400859